Rights Offering for Opexa Therapeutics, Inc.

Represented Maxim Group LLC as lead dealer-manager and National Securities Corporation as co-dealer-manager in a $13.8 million rights offering for Opexa Therapeutics, Inc., a NASDAQ-listed biotechnology company.